NCT01034254
Field Trial of Maternal Influenza Immunization in Asia prevention 3 completed NCT00774774
Face Masks for Preventing Influenza Transmission No drug interventions prevention 4 completed NCT00863343
Clinical Validation of the Point-of-Care MSD Influenza Test No drug interventions Not Available Not Available terminated NCT05596734
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza prevention 1 / 2 completed NCT05648448
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza treatment 2 recruiting NCT06087640
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age prevention 3 active_not_recruiting NCT06566534
Personalized Nudging to Increase Influenza Vaccinations No drug interventions prevention Not Available recruiting NCT06622590
Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine No drug interventions prevention 1 not_yet_recruiting NCT06237049
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults prevention 2 completed NCT05223179
Intramuscular CodaVax-H1N1 in Healthy Adults prevention 1 completed NCT05858450
This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times. Not Available Not Available completed NCT05875961
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults No drug interventions prevention 1 active_not_recruiting NCT05975840
Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults No drug interventions prevention 1 / 2 completed NCT06015282
The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older No drug interventions prevention 3 active_not_recruiting NCT06028347
Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying mRNA Influenza Vaccine in Healthy Adults No drug interventions prevention 1 active_not_recruiting NCT06602531
Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults No drug interventions prevention 1 not_yet_recruiting NCT05269290
Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections treatment 3 completed NCT02621164
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents prevention 3 completed NCT04288921
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites No drug interventions diagnostic Not Available recruiting NCT06385821
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus No drug interventions prevention 3 completed NCT01688921
Jet Injection for Influenza prevention 4 completed NCT05514002
Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years prevention 4 terminated NCT01428479
Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males treatment 1 completed NCT03460743
Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. No drug interventions other 3 completed NCT03438487
Flucelvax (TIVc or QIVc) Pregnancy Registry Not Available Not Available completed NCT04038333
Financing Strategies of Influenza Vaccination in China No drug interventions Not Available Not Available completed NCT01863433
A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers No drug interventions prevention 4 completed NCT02921633
Childhood Influenza Immunisation in General Practice Invitation Trial No drug interventions prevention Not Available completed NCT04565353
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates No drug interventions health_services_research Not Available completed NCT02582047
Influenza Vaccine and Pneumococcal Vaccine No drug interventions prevention 4 completed NCT03824847
Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community treatment 4 suspended NCT04080245
Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV) No drug interventions basic_science 0 recruiting NCT02019745
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers Not Available Not Available completed NCT05138705
Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years No drug interventions prevention 4 completed NCT01674205
Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines basic_science 1 completed NCT01857297
A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers prevention 4 completed NCT05052697
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza No drug interventions prevention 1 / 2 completed NCT05711797
Pharmacokinetic Characteristics of Subjects With Hepatic Insufficiency and Healthy Subjects No drug interventions treatment 1 recruiting NCT03020628
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months No drug interventions prevention 3 completed NCT01314911
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults treatment Not Available completed NCT05110911
Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection Not Available Not Available recruiting NCT06382311
A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults No drug interventions prevention 1 / 2 recruiting NCT03899571
Prophylactic Treatment With Oseltamivir prevention Not Available completed NCT02964871
Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities No drug interventions treatment Not Available completed NCT02632578
Influenza Vaccine in HIV Study No drug interventions Not Available Not Available completed NCT01014988
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital treatment 2 completed NCT02950688
Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus prevention 1 withdrawn NCT03394209
A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza treatment 2 completed NCT01808456
Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant. prevention 4 completed NCT04366115
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS treatment 1 not_yet_recruiting NCT03189537
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections prevention 3 completed NCT06355232
Covid-19 and Influenza Oral Vaccine Study No drug interventions prevention 1 recruiting NCT05079152
Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 No drug interventions prevention 4 unknown_status NCT06315400
Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections treatment 4 recruiting NCT02585700
A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine No drug interventions prevention 1 completed NCT04160975
Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects No drug interventions health_services_research Not Available completed NCT03614975
Immunologic Response to Influenza Vaccination in Children and Adolescents prevention 4 completed NCT01286142
Oseltamivir Infant Influenza Safety Study No drug interventions Not Available Not Available completed NCT02212106
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years prevention 4 completed NCT02996136
Assessment of the Clinical Performance of the ARROW-FLU System No drug interventions diagnostic Not Available unknown_status NCT02957136
Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department No drug interventions health_services_research Not Available completed NCT03283319
Panblok H7 Vaccine Adjuvanted With AS03 or MF59 No drug interventions prevention 2 completed NCT05273619
Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection No drug interventions treatment 3 completed NCT03657719
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects No drug interventions prevention 2 completed NCT02998996
Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU No drug interventions prevention 1 / 2 completed NCT03768596
Nudging for Vaccination : Efficacity and Acceptability Among Medical Students No drug interventions basic_science Not Available completed NCT02867358
A Clinical Trial of KT07 Capsule in the U.S.A No drug interventions treatment 2 completed NCT03357263
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults No drug interventions prevention 1 completed NCT03599739
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey No drug interventions Not Available Not Available completed NCT02214225
A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. No drug interventions prevention 3 completed NCT01390025
Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza No drug interventions treatment 1 completed NCT00545025
Revaccination With Influenza Vaccine GSK1247446A prevention 2 completed NCT02755948
A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers basic_science Not Available terminated NCT04590066
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy No drug interventions health_services_research Not Available completed NCT02108366
Treatment of Severe Influenza A Infection treatment 3 completed NCT02899065
Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department No drug interventions health_services_research Not Available completed NCT02243774
Mail Outreach To Increase Vaccination Acceptance Through Engagement No drug interventions treatment Not Available completed NCT05823974
A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults No drug interventions prevention 1 / 2 active_not_recruiting NCT02655874
Tropical Influenza Control Strategies for the Elderly prevention 4 completed NCT01231620
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza treatment 3 completed NCT03688620
Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season No drug interventions prevention 4 completed NCT03932682
Efficacy Study With QIVc in Pediatric Subjects prevention 3 completed NCT00995982
VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years No drug interventions prevention 1 completed NCT05470582
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old prevention 3 completed NCT00929331
Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years prevention 3 completed NCT01810731
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya prevention 2 / 3 withdrawn NCT01587131
DNA-based Influenza Vaccine in the Elderly No drug interventions prevention 1 completed NCT03294473
Centralized Reminder Recall - Flu RCT2 No drug interventions health_services_research Not Available completed NCT01591473
Safety Study of FluMist With and Without Ampligen prevention 1 / 2 terminated NCT02225327
MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine prevention 4 completed NCT04120194
Phase 3 Pivotal Trial of NanoFlu™ in Older Adults prevention 3 completed NCT03502291
The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study health_services_research 4 completed NCT01369862
Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults No drug interventions prevention 1 / 2 completed NCT03339180
Cardiac Injury in Patients With Influenza No drug interventions Not Available Not Available unknown_status NCT02500680
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) No drug interventions prevention 1 unknown_status NCT06207929
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections No drug interventions Not Available Not Available completed NCT03658629
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults prevention 2 terminated NCT01353729
A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers No drug interventions other 1 completed NCT05012189
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks prevention 4 active_not_recruiting NCT01390792
Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis) Not Available Not Available completed NCT03332992
Comparative Tests of Flu Vaccination Phone Messages No drug interventions health_services_research Not Available completed NCT01199744
Relenza® Sentinel Site Monitoring Program in Japan Not Available Not Available completed NCT05446740
A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults No drug interventions prevention 1 completed NCT03278067
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England No drug interventions Not Available Not Available completed NCT02377401
Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults treatment 1 completed NCT05227001
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza No drug interventions prevention 1 completed NCT02917304
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older No drug interventions prevention 3 completed NCT01967368
Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults prevention 4 unknown_status NCT03982069
Immunologic Response to FluMist vs. Flucelvax prevention 4 completed NCT02885246
Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015 No drug interventions Not Available Not Available completed NCT05981846
A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19 prevention 2 completed NCT04494412
An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection treatment 2 recruiting NCT04172610
Prevalence of Influenza RelAted Invasive Aspergillosis No drug interventions Not Available Not Available completed NCT02786381
Idylla IFV-RSV Panel Clinical Testing No drug interventions Not Available Not Available completed NCT05044195
A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age No drug interventions prevention 3 completed NCT04527614
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection No drug interventions diagnostic Not Available completed NCT05765955
Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses No drug interventions treatment 1 completed NCT06573008
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications No drug interventions treatment 3 not_yet_recruiting NCT02545543
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age prevention 3 completed NCT02741843
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly No drug interventions health_services_research Not Available completed NCT06436703
A Study About Modified RNA Vaccines Against Influenza in Healthy Adults No drug interventions prevention 1 / 2 active_not_recruiting NCT02957890
Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong No drug interventions prevention 4 active_not_recruiting NCT01906190
Persistence of Immune Response After Vaccination With Influenza Vaccine No drug interventions prevention Not Available completed NCT02663102
Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea. No drug interventions Not Available Not Available completed NCT01462487
Safety of Inhaled Zanamivir in Pregnancy Not Available Not Available completed NCT04790851
Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 No drug interventions prevention 4 completed NCT02621177
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents prevention 3 completed NCT04576377
Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures prevention 4 active_not_recruiting NCT04789577
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older No drug interventions prevention 2 completed NCT04441047
Universal Anti-Viral Vaccine for Healthy Elderly Adults No drug interventions prevention 1 / 2 completed NCT03196245
NK Cell Mediated Influenza Immunity During Pregnancy No drug interventions Not Available Not Available terminated NCT02480998
Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults No drug interventions treatment 1 / 2 completed NCT03191097
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o. treatment 3 completed NCT05501561
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age No drug interventions prevention 2 completed NCT00858611
VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat... prevention 1 completed NCT01710111
Evaluating Modes of Influenza Transmission No drug interventions basic_science Not Available completed NCT00776711
Vaccine for Prevention of Bird Flu No drug interventions prevention 1 completed NCT02893878
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines No drug interventions Not Available Not Available completed NCT01407978
Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents No drug interventions prevention Not Available completed NCT03743688
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults Not Available Not Available completed NCT02107807
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine No drug interventions prevention 3 completed NCT06431607
A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults No drug interventions prevention 2 active_not_recruiting NCT03392207
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) No drug interventions Not Available Not Available completed NCT02915809
A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults No drug interventions prevention 3 unknown_status NCT03154515
Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults treatment 4 completed NCT01591837
A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers prevention 4 completed NCT03330132
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong No drug interventions prevention 4 active_not_recruiting NCT00545532
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants. treatment 3 completed NCT04244500
Burden of Influenza at Emergency Department (ED) Level in European Countries No drug interventions Not Available Not Available unknown_status NCT00644059
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines prevention 3 completed NCT03736759
Resistance Exercise to Improve Flu Vaccine for Older Adults No drug interventions supportive_care Not Available completed NCT02914275
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. No drug interventions prevention 3 completed NCT03095599
Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3 No drug interventions prevention 2 / 3 completed NCT00558649
A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines prevention Not Available completed NCT02101749
Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group. No drug interventions prevention 4 completed NCT05874713
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults No drug interventions prevention 2 active_not_recruiting NCT05108818
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults No drug interventions basic_science 4 recruiting NCT04372719
A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers No drug interventions other 1 completed NCT03165617
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age prevention 3 completed NCT02344134
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects prevention 3 completed NCT03028116
Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine No drug interventions prevention 1 completed NCT03035396
Clinical Performance of the Diassess Influenza A and B Test No drug interventions device_feasibility Not Available completed NCT05540522
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older No drug interventions prevention 3 completed NCT01258530
A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers other 1 completed NCT05921448
Vaccine Pandemic Preparedness Through Airway Immunology Characterization prevention 0 not_yet_recruiting NCT05648357
A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India prevention 4 completed NCT05422326
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed No drug interventions prevention 2 completed NCT05739474
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children No drug interventions prevention 3 recruiting NCT05779020
Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children . No drug interventions prevention 3 recruiting NCT03442582
Afluria Pregnancy Registry Not Available Not Available completed NCT03927131
Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine No drug interventions prevention 3 active_not_recruiting NCT01753531
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B No drug interventions Not Available Not Available completed NCT05955027
A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects No drug interventions treatment 1 not_yet_recruiting NCT03748160
Herd Immunity and Influenza Vaccine Uptake No drug interventions prevention Not Available completed NCT05457894
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women No drug interventions prevention 3 completed NCT06125691
Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults No drug interventions prevention 1 active_not_recruiting NCT02290691
Inactivated Influenza Via Jet Injection No drug interventions prevention 4 completed NCT05720091
Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China No drug interventions treatment 1 not_yet_recruiting NCT04669691
A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine No drug interventions prevention 2 completed NCT03410862
Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza No drug interventions treatment 4 completed NCT03314662
Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults No drug interventions prevention 3 completed NCT02984280
Specific Respiratory Infections as Triggers of Acute Medical Events No drug interventions Not Available Not Available completed NCT05269329
Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection No drug interventions treatment 2 completed NCT01381029
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals No drug interventions Not Available Not Available completed NCT02352389
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents No drug interventions Not Available Not Available completed NCT05702489
A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults With Uncomplicated Influenza No drug interventions treatment 2 / 3 recruiting NCT03275389
A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years prevention 1 completed NCT02598089
Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) No drug interventions prevention 1 completed NCT04568044
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy No drug interventions Not Available Not Available active_not_recruiting NCT05869201
Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine No drug interventions prevention 2 / 3 completed NCT01156701
Prophylactic Efficacy of Relenza Against Influenza A and B Not Available Not Available completed NCT01078701
Dose Finding Study of Single Dose GHB11L1 in Healthy Adults No drug interventions prevention 2 completed NCT05827601
Zoonotic Influenza Surveillance in Belgium No drug interventions Not Available Not Available enrolling_by_invitation NCT04559204
Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4 No drug interventions prevention 4 completed NCT02883972
Childhood Influenza Immunisation Invitation Trial in Schools No drug interventions other Not Available withdrawn NCT03445468
Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents No drug interventions prevention 3 completed NCT03206346
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o. treatment 3 completed NCT02723812
Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old No drug interventions prevention 4 completed NCT01527110
A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection treatment 3 completed NCT03965195
Recombinant Influenza Vaccination in U.S. Nursing Homes prevention 4 active_not_recruiting NCT03239795
Promoting Influenza Vaccination In General Practice Waiting Rooms No drug interventions prevention Not Available completed NCT00803595
A Multinational Phase III Study of CS-8958 (MARVEL) treatment 3 completed NCT02831608
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis treatment 4 completed NCT02091908
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions No drug interventions prevention 3 completed NCT03778203
Development of Childhood Anti-influenza Immunity basic_science 4 recruiting NCT03133936
Evaluation of the Effects of Age, Prior Exposure, and Previous Vaccination on Response to the Flu Vaccine basic_science Not Available completed NCT01636102
Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above No drug interventions prevention 2 completed NCT01879553
Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above No drug interventions prevention 2 completed NCT02398097
Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects No drug interventions prevention 4 completed NCT01677715
Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System No drug interventions prevention Not Available completed NCT01690637
Panama and El Salvador Children's Oseltamivir Study treatment 4 terminated NCT00880659
Bangladesh Secondary Transmission Handwashing Protocol No drug interventions prevention 2 completed NCT05155319
Universal Influenza A Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT04487041
Tfh Dysfunction in HIV and Aging basic_science 4 recruiting NCT01885117
Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above No drug interventions prevention 3 completed NCT01342796
Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects No drug interventions prevention 2 completed NCT02387294
Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents No drug interventions prevention 3 completed NCT04682444
Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza. No drug interventions treatment 2 / 3 completed NCT01511744
Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine No drug interventions prevention 4 completed NCT02104869
Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients No drug interventions prevention 4 completed NCT04431050
Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens No drug interventions Not Available Not Available unknown_status NCT01677702
Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization No drug interventions prevention Not Available completed NCT03448705
Safety of 4Fluart ID Suspension for Injection in Adult Subjects No drug interventions prevention 1 completed NCT02478905
Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting No drug interventions Not Available Not Available completed NCT01880697
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above No drug interventions prevention 3 completed NCT01568788
Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine prevention Not Available completed NCT02600585
Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults Not Available Not Available completed NCT01096225
Immunogenicity Study of S-OIV H1N1 Influenza Vaccine No drug interventions Not Available Not Available unknown_status NCT03572491
Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine No drug interventions prevention 3 completed NCT01879540
Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age No drug interventions prevention 2 completed NCT01651104
Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects No drug interventions prevention 2 completed NCT02427750
A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects. No drug interventions prevention 2 completed